Facioscapulohumeral Muscular Dystrophy (FSHD)
7 clinical trials · Condition
◉ Watch Facioscapulohumeral Muscular Dystrophy (FSHD)
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH) (NCT05397470) | Fulcrum Therapeutics | 2022-06-16 |
| Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE) (NCT04264442) | Fulcrum Therapeutics | 2020-02-13 |
| Efficacy and Safety of Losmapimod in Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) (NCT04003974) | Fulcrum Therapeutics | 2019-08-09 |
| Evaluate Safety and Biological Activity of ATYR1940 in Participants With Early Onset Facioscapulohumeral Muscular Dystrophy (NCT02603562) | aTyr Pharma, Inc. | 2016-03-30 |
Track Facioscapulohumeral Muscular Dystrophy (FSHD) automatically
Every clearance here is in the API, with alerts when new ones post.